Market Research Logo

Global Nasopharyngeal Cancer Market - Segmented by Type of Therapy, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Nasopharyngeal Cancer Market - Segmented by Type of Therapy, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The global nasopharyngeal cancer market is projected to record a CAGR of approximately 2%, during the forecast period (2018-2023).

Growing Awareness towards Diagnosis and Treatment of Nasopharyngeal Cancer

There is a growing awareness towards diagnosis and treatment of nasopharyngeal cancer (NPC). Traditionally the public perception regarding nasopharyngeal cancer was very weak due to lack of government initiatives and low incidence rate of the disease. But, the rise in the number of NPC patients in North America region has changed this scenario. In the United States, nasopharyngeal carcinoma (NPC) is a rare malignancy of the upper digestive tract and has an incidence of less than 1 per 100,000. However, this disease has a well-documented regional and ethnic distribution such that individuals of Southern Chinese and Southeast Asian descent are up to 20-40 times more likely to develop NPC than individuals of European ethnicity. To increase the community awareness for ethnicities, which are predisposed to nasopharyngeal cancer, various primary healthcare centers have started awareness drive to increase the awareness on NPC. Consequently, greater adoption of NPC diagnosis and treatment is being witnessed, which is driving the growth of the global nasopharyngeal cancer market. Additionally, factors, like high prevalence of the NPC in regions of North America and Southern China, are also contributing to market growth.

Considerably Low Incidence Rate of Disease

Cancer of the nasopharynx is one of the most common cancers of neck and head, yet their overall global prevalence is considerably low. This is primarily due to the fact, that the incidence rate of the disease is not uniform across various regions and there is high concentration of nasopharyngeal cancer patients in some regions while almost close to zero prevalence in most other regions. For example, in Asia the Southeast region has the highest prevalence of nasopharyngeal cancer with prevalence rate of approximately 15 patients per 100,000 people. The prevalence rate in US and other regions of the world is less than 1 per 100,000 people. Consequently, this orphan status of the disease in overall global setting hinders the growth of the global nasopharyngeal cancer market, as drug manufacturers do not find the related drug development a lucrative business option due to overall low global incidence. Additionally, factors, like adverse side effects associated with current therapies and drugs indicated for nasopharyngeal cancer and lack of financial backing for research & development of blockbuster drugs are hindering the market growth.

Radiation Therapy has the largest market share

Radiation therapy forms the primary modality of treatment in nasopharyngeal cancer. It is closely followed by chemotherapy in terms of both market share and use-case in patients. Newer and advanced modalities of nasopharyngeal cancer treatment include combination of both radiotherapy and chemotherapy techniques. These treatment modalities are still in early clinical phases and will make commercial appearance late during the end of forecast period or maybe even after that.

Major players - BRISTOL MYERS SQUIBB, SANOFI, MERCK, PFIZER, ELI LILLY AND COMPANY, NOVARTIS, HOFFMANN-LA ROCHE AND BIOCON, among others.

Reasons to Purchase this Report

  • Current and future global nasopharyngeal cancer market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identifying the latest developments, market shares, and strategies employed by the major market players
  • 3 month analyst support, along with the Market Estimate sheet (in Excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product And Services
5.2.5 Competitive Rivalry Within The Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 High Prevalence in Regions, like North America, Southern China, and Canada
6.1.2 Growing Awareness Towards Diagnosis and Treatment of Nasopharyngeal Cancer
6.2 Market Restraints
6.2.1 Lack of Financial Backing for Research & Development of Blockbuster Drugs
6.2.2 Considerably Low Incidence Rate of the Disease
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Therapy
7.1.1 Radiation Therapy
7.1.1.1 External Beam Radiation Therapy
7.1.1.2 Proton Therapy
7.1.1.3 Stereotactic Radiosurgery
7.1.1.4 Brachytherapy
7.1.2 Chemotherapy
7.1.2.1 Cisplatin
7.1.2.2 Fluorouracil (5-FU)
7.1.2.3 Docetaxel
7.1.2.4 Paclitaxel
7.1.2.5 Gemcitabine
7.1.3 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 US
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 UK
7.2.2.2 Germany
7.2.2.3 France
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, And Partnerships
8.3 New Products Launches
9. Key Players
9.1 Biocon
9.2 Bristol Myers Squibb
9.3 Eli Lilly and Company
9.4 Hoffman La-Roche
9.5 Merck
9.6 Novartis
9.7 Pfizer
9.8 Sanofi
*List Not Exhaustive
10. Future of The Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report